Understanding Alzheimer's Disease

The video explores the causes and progression of Alzheimer's disease, focusing on the accumulation of toxic proteins like A-beta, tau, and alpha synuclein. It discusses recent advancements in imaging and biomarkers that help track these proteins. An analogy is used to explain the complexity of disease progression. The video also highlights the development of endobodies to target and remove toxic proteins, aiming for early intervention and prevention.

Which proteins are primarily implicated in Alzheimer's disease?

• Collagen, elastin, and keratin

• Hemoglobin, myoglobin, and ferritin

• Insulin, glucagon, and leptin

• A-beta, tau, and alpha synuclein

What is the analogy used to describe the cascade of events in Alzheimer's?

• A chain reaction in a chemical experiment

• A ripple effect in a pond

• A small poke leading to a series of events in a sports bar

• A domino effect in a line of falling tiles

How long before symptoms appear do toxic proteins start accumulating in the brain?

• 30-40 years

• 10-20 years

• 1-2 years

• 5-10 years

What is the goal of creating endobodies in Alzheimer's treatment?

• To reduce inflammation in the brain

• To increase the production of neurotransmitters

• To cross the blood-brain barrier and engage toxic A-beta plaque

• To enhance memory retention

What is the process of protein aggregation leading to plaque formation?

• Monomer, dimer, trimer, polymer

• Polymer, monomer, fibril, plaque

• Dimer, oligomer, fibril, plaque

• Oligomer, monomer, dimer, plaque

What is United Neuroscience's approach to treating Alzheimer's?

• Creating a new exercise regimen

• Activating the immune system to target toxic proteins

• Using gene therapy to alter DNA

• Developing a new diet plan

What is the primary target of United Neuroscience's lead compound?

• Tau proteins

• Alpha synuclein

• Insulin

• Beta amyloid

What is the potential benefit of early intervention in Alzheimer's?

• Enhancing cognitive abilities

• Curing the disease completely

• Preventing the accumulation of toxic proteins

• Reversing existing symptoms

How does United Neuroscience plan to make their treatment accessible?

• By limiting the treatment to specific regions

• By partnering with insurance companies

• By using a cost-effective technology platform

• By offering free treatments

What is the ultimate goal of United Neuroscience's research?

• To publish groundbreaking research papers

• To change people's lives and make them better

• To develop a new type of medication

• To create a new diagnostic tool